Hydroxychloroquine in Giant Cell Arteritis

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

January 31, 2005

Study Completion Date

December 31, 2006

Conditions
Giant Cell Arteritis
Interventions
DRUG

hydroxychloroquine/placebo

Trial Locations (23)

14033

University Hospital Côte de Nacre, Caen

14100

Hospital, Lisieux

21035

University Hospital Dijon, Dijon

25030

University Hospital Besançon, Besançon

31059

University Hospital Toulouse, Toulouse

University Hospital, Toulouse

32008

Hospital Auch, Auch

34525

Hospital Béziers, Béziers

37044

University Hospital Bretonneau, Tours

44035

University Hospital, Nantes

47923

Hospital, Agen

65107

Hospital, Lourdes

75010

Saint Louis Hospital, Paris

75012

University Hospital Saint Antoine, Paris

75018

University Hospital Bichat, Paris

81000

Hospital, Albi

81200

Hospital, Mazamet

81500

Hospital, Lavaur

82013

Hospital, Montauban

84902

Hospital Avignon, Avignon

87042

University Hospital Dupuytren, Limoges

92151

Hospital Suresnes, Suresnes

09017

Hospital, Foix

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT00430807 - Hydroxychloroquine in Giant Cell Arteritis | Biotech Hunter | Biotech Hunter